Mediolanum International Funds LTD Argenx Se Transaction History

Mediolanum International Funds LTD

  • $7.71 Trillion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
BUY
$434.22 - $551.9 $2.3 Million - $2.92 Million
5,290 Added 49.47%
15,984 $8.55 Billion
Q2 2024

Aug 13, 2024
SELL
$356.01 - $451.55 $274,839 - $348,596
-772 Reduced 6.73%
10,694 $4.44 Billion
Q1 2024

May 03, 2024
BUY
$356.95 - $413.29 $4.09 Million - $4.74 Million
11,466 New
11,466 $4.57 Billion

Others Institutions Holding ARGX

# of Institutions
413
Shares Held
31M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $36.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Mediolanum International Funds LTD Portfolio

Follow Mediolanum International Funds LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mediolanum International Funds LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mediolanum International Funds LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email